Vandewouw, Marlee M. https://orcid.org/0000-0002-4505-0306
Safar, Kristina
Mossad, Sarah I.
Lu, Julie
Lerch, Jason P.
Anagnostou, Evdokia
Taylor, Margot J.
Funding for this research was provided by:
Ontario Brain Institute (IDS-I l-02)
Article History
Received: 10 June 2021
Revised: 16 August 2021
Accepted: 26 August 2021
First Online: 25 September 2021
Competing interests
: E. Anagnostou has served as a consultant to Roche and Quadrant Therapeutics, has received consultation fees from Roche, holds a patent for the device, “Anxiety Meter”, and has received in-kind support from AMO pharma, royalties from APPI and Springer, and editorial honoraria from Wiley. The remaining authors (M.M. Vandewouw, K. Safar, S.I. Mossad, J. Lu, J.P. Lerch and M.J. Taylor) have reported no biomedical financial interests or potential conflicts of interest.